7.7 |
23.1 |
GO:0010273 |
detoxification of copper ion(GO:0010273) stress response to copper ion(GO:1990169) |
6.2 |
18.5 |
GO:2000064 |
regulation of cortisol biosynthetic process(GO:2000064) |
4.4 |
4.4 |
GO:0072010 |
renal filtration cell differentiation(GO:0061318) glomerular epithelium development(GO:0072010) glomerular visceral epithelial cell differentiation(GO:0072112) glomerular epithelial cell differentiation(GO:0072311) |
4.2 |
12.7 |
GO:0010757 |
negative regulation of plasminogen activation(GO:0010757) |
4.2 |
12.6 |
GO:0019747 |
regulation of isoprenoid metabolic process(GO:0019747) |
3.9 |
19.6 |
GO:0033484 |
nitric oxide homeostasis(GO:0033484) |
3.6 |
14.4 |
GO:0030913 |
paranodal junction assembly(GO:0030913) |
3.2 |
9.5 |
GO:0060539 |
diaphragm development(GO:0060539) |
3.1 |
18.5 |
GO:0032926 |
negative regulation of activin receptor signaling pathway(GO:0032926) |
2.9 |
32.3 |
GO:0046628 |
positive regulation of insulin receptor signaling pathway(GO:0046628) positive regulation of cellular response to insulin stimulus(GO:1900078) |
2.8 |
8.3 |
GO:0051541 |
elastin metabolic process(GO:0051541) |
2.8 |
13.9 |
GO:0055098 |
response to low-density lipoprotein particle(GO:0055098) |
2.7 |
18.6 |
GO:2000111 |
positive regulation of macrophage apoptotic process(GO:2000111) |
2.6 |
28.4 |
GO:0050872 |
white fat cell differentiation(GO:0050872) |
2.5 |
10.2 |
GO:0048619 |
embryonic hindgut morphogenesis(GO:0048619) |
2.5 |
17.6 |
GO:0030007 |
cellular potassium ion homeostasis(GO:0030007) negative regulation of cell volume(GO:0045794) |
2.4 |
7.3 |
GO:0008218 |
bioluminescence(GO:0008218) |
2.4 |
35.4 |
GO:0034446 |
substrate adhesion-dependent cell spreading(GO:0034446) |
2.4 |
7.1 |
GO:0043371 |
negative regulation of CD4-positive, alpha-beta T cell differentiation(GO:0043371) negative regulation of T-helper cell differentiation(GO:0045623) negative regulation of CD4-positive, alpha-beta T cell activation(GO:2000515) |
2.1 |
12.9 |
GO:0007386 |
compartment pattern specification(GO:0007386) |
2.0 |
6.1 |
GO:0070208 |
protein heterotrimerization(GO:0070208) |
2.0 |
2.0 |
GO:0097709 |
connective tissue replacement involved in inflammatory response wound healing(GO:0002248) connective tissue replacement(GO:0097709) |
2.0 |
6.1 |
GO:0048319 |
axial mesoderm morphogenesis(GO:0048319) |
2.0 |
2.0 |
GO:0031638 |
zymogen activation(GO:0031638) |
2.0 |
6.0 |
GO:0048627 |
myoblast development(GO:0048627) |
2.0 |
11.8 |
GO:0006931 |
substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
2.0 |
15.6 |
GO:0003065 |
regulation of heart rate by chemical signal(GO:0003062) positive regulation of heart rate by epinephrine(GO:0003065) |
1.9 |
5.8 |
GO:0061030 |
epithelial cell differentiation involved in mammary gland alveolus development(GO:0061030) |
1.9 |
3.9 |
GO:0007412 |
axon target recognition(GO:0007412) |
1.9 |
7.8 |
GO:0030035 |
microspike assembly(GO:0030035) |
1.9 |
9.7 |
GO:1903960 |
negative regulation of plasma membrane long-chain fatty acid transport(GO:0010748) negative regulation of anion transmembrane transport(GO:1903960) negative regulation of fatty acid transport(GO:2000192) |
1.9 |
3.8 |
GO:0070296 |
sarcoplasmic reticulum calcium ion transport(GO:0070296) |
1.8 |
7.3 |
GO:0090162 |
establishment of epithelial cell polarity(GO:0090162) |
1.8 |
16.5 |
GO:0060666 |
dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
1.8 |
7.2 |
GO:2001258 |
negative regulation of ryanodine-sensitive calcium-release channel activity(GO:0060315) negative regulation of calcium ion transmembrane transporter activity(GO:1901020) negative regulation of cation channel activity(GO:2001258) |
1.8 |
10.8 |
GO:0070141 |
response to UV-A(GO:0070141) |
1.8 |
3.5 |
GO:0010908 |
regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010908) positive regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010909) canonical Wnt signaling pathway involved in positive regulation of epithelial to mesenchymal transition(GO:0044334) positive regulation of proteoglycan biosynthetic process(GO:1902730) |
1.8 |
5.3 |
GO:0021837 |
motogenic signaling involved in postnatal olfactory bulb interneuron migration(GO:0021837) regulation of mesodermal cell fate specification(GO:0042661) lateral mesoderm development(GO:0048368) lateral mesoderm morphogenesis(GO:0048369) lateral mesoderm formation(GO:0048370) lateral mesodermal cell differentiation(GO:0048371) lateral mesodermal cell fate commitment(GO:0048372) lateral mesodermal cell fate specification(GO:0048377) regulation of lateral mesodermal cell fate specification(GO:0048378) regulation of mesoderm development(GO:2000380) |
1.8 |
3.5 |
GO:0043114 |
regulation of vascular permeability(GO:0043114) |
1.7 |
6.9 |
GO:0010882 |
regulation of cardiac muscle contraction by calcium ion signaling(GO:0010882) |
1.7 |
5.1 |
GO:0060599 |
lateral sprouting involved in mammary gland duct morphogenesis(GO:0060599) |
1.7 |
1.7 |
GO:0060716 |
labyrinthine layer blood vessel development(GO:0060716) |
1.6 |
8.2 |
GO:0002036 |
regulation of L-glutamate transport(GO:0002036) |
1.6 |
3.2 |
GO:0003176 |
aortic valve development(GO:0003176) aortic valve morphogenesis(GO:0003180) notochord formation(GO:0014028) |
1.6 |
11.2 |
GO:0051386 |
regulation of neurotrophin TRK receptor signaling pathway(GO:0051386) |
1.6 |
8.0 |
GO:0006927 |
obsolete transformed cell apoptotic process(GO:0006927) |
1.5 |
3.0 |
GO:2000008 |
regulation of protein localization to cell surface(GO:2000008) |
1.5 |
6.0 |
GO:0042271 |
susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
1.5 |
4.4 |
GO:0051088 |
PMA-inducible membrane protein ectodomain proteolysis(GO:0051088) |
1.4 |
1.4 |
GO:0072048 |
pattern specification involved in kidney development(GO:0061004) renal system pattern specification(GO:0072048) |
1.4 |
4.3 |
GO:0060831 |
smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:0060831) |
1.4 |
4.1 |
GO:0002689 |
negative regulation of leukocyte chemotaxis(GO:0002689) |
1.4 |
8.2 |
GO:0060346 |
bone trabecula formation(GO:0060346) bone trabecula morphogenesis(GO:0061430) |
1.4 |
1.4 |
GO:0090244 |
Wnt signaling pathway involved in somitogenesis(GO:0090244) |
1.3 |
8.1 |
GO:2000124 |
cannabinoid signaling pathway(GO:0038171) endocannabinoid signaling pathway(GO:0071926) regulation of endocannabinoid signaling pathway(GO:2000124) |
1.3 |
2.7 |
GO:0046836 |
glycolipid transport(GO:0046836) |
1.3 |
5.3 |
GO:0033986 |
response to methanol(GO:0033986) response to chromate(GO:0046687) |
1.3 |
4.0 |
GO:0021823 |
cerebral cortex tangential migration using cell-cell interactions(GO:0021823) substrate-dependent cerebral cortex tangential migration(GO:0021825) postnatal olfactory bulb interneuron migration(GO:0021827) |
1.3 |
6.6 |
GO:0031953 |
negative regulation of protein autophosphorylation(GO:0031953) |
1.3 |
4.0 |
GO:0018377 |
N-terminal protein myristoylation(GO:0006499) protein myristoylation(GO:0018377) |
1.3 |
13.1 |
GO:0001967 |
suckling behavior(GO:0001967) |
1.3 |
3.9 |
GO:0001705 |
ectoderm formation(GO:0001705) |
1.3 |
7.8 |
GO:0014912 |
negative regulation of smooth muscle cell migration(GO:0014912) |
1.3 |
5.1 |
GO:0060209 |
estrus(GO:0060209) |
1.3 |
3.8 |
GO:0032927 |
positive regulation of activin receptor signaling pathway(GO:0032927) |
1.3 |
6.3 |
GO:0048625 |
myoblast fate commitment(GO:0048625) |
1.3 |
8.9 |
GO:0014049 |
positive regulation of glutamate secretion(GO:0014049) |
1.3 |
6.3 |
GO:0051045 |
negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
1.2 |
7.4 |
GO:2000172 |
regulation of branching morphogenesis of a nerve(GO:2000172) |
1.2 |
3.7 |
GO:0043276 |
anoikis(GO:0043276) |
1.2 |
1.2 |
GO:0061298 |
retina vasculature development in camera-type eye(GO:0061298) retina vasculature morphogenesis in camera-type eye(GO:0061299) |
1.2 |
3.7 |
GO:0061117 |
negative regulation of cardiac muscle tissue growth(GO:0055022) negative regulation of cardiac muscle tissue development(GO:0055026) negative regulation of cardiac muscle cell proliferation(GO:0060044) negative regulation of heart growth(GO:0061117) |
1.2 |
3.7 |
GO:0006015 |
5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
1.2 |
3.6 |
GO:0034036 |
purine ribonucleoside bisphosphate biosynthetic process(GO:0034036) 3'-phosphoadenosine 5'-phosphosulfate biosynthetic process(GO:0050428) |
1.2 |
4.8 |
GO:0009609 |
response to symbiont(GO:0009608) response to symbiotic bacterium(GO:0009609) |
1.2 |
4.8 |
GO:0045715 |
negative regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045715) |
1.2 |
4.8 |
GO:0046108 |
uridine metabolic process(GO:0046108) |
1.2 |
9.4 |
GO:0033631 |
cell-cell adhesion mediated by integrin(GO:0033631) |
1.2 |
7.0 |
GO:0010591 |
regulation of lamellipodium assembly(GO:0010591) |
1.2 |
17.5 |
GO:0060391 |
positive regulation of SMAD protein import into nucleus(GO:0060391) |
1.1 |
1.1 |
GO:0010040 |
response to iron(II) ion(GO:0010040) |
1.1 |
22.7 |
GO:0035329 |
hippo signaling(GO:0035329) |
1.1 |
4.5 |
GO:0090161 |
Golgi ribbon formation(GO:0090161) |
1.1 |
3.3 |
GO:0034626 |
fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
1.1 |
4.4 |
GO:0060325 |
face morphogenesis(GO:0060325) |
1.1 |
3.3 |
GO:0071071 |
regulation of phosphatidylinositol biosynthetic process(GO:0010511) regulation of phospholipid biosynthetic process(GO:0071071) |
1.1 |
3.2 |
GO:0045112 |
integrin biosynthetic process(GO:0045112) |
1.1 |
3.2 |
GO:0002575 |
basophil chemotaxis(GO:0002575) |
1.1 |
3.2 |
GO:0007500 |
mesodermal cell fate determination(GO:0007500) |
1.0 |
6.3 |
GO:0006011 |
UDP-glucose metabolic process(GO:0006011) |
1.0 |
5.2 |
GO:0019471 |
peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) 4-hydroxyproline metabolic process(GO:0019471) peptidyl-proline hydroxylation(GO:0019511) |
1.0 |
3.1 |
GO:0003011 |
diaphragm contraction(GO:0002086) involuntary skeletal muscle contraction(GO:0003011) |
1.0 |
4.1 |
GO:0072180 |
nephric duct morphogenesis(GO:0072178) mesonephric duct morphogenesis(GO:0072180) |
1.0 |
7.1 |
GO:0030579 |
ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
1.0 |
17.0 |
GO:0050812 |
acetyl-CoA biosynthetic process from pyruvate(GO:0006086) regulation of acetyl-CoA biosynthetic process from pyruvate(GO:0010510) regulation of acyl-CoA biosynthetic process(GO:0050812) |
1.0 |
3.0 |
GO:0045743 |
positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
1.0 |
3.0 |
GO:0060596 |
mammary placode formation(GO:0060596) |
1.0 |
4.0 |
GO:0051894 |
positive regulation of focal adhesion assembly(GO:0051894) positive regulation of cell junction assembly(GO:1901890) positive regulation of adherens junction organization(GO:1903393) |
1.0 |
3.0 |
GO:0070672 |
response to interleukin-15(GO:0070672) |
1.0 |
1.0 |
GO:0090594 |
wound healing involved in inflammatory response(GO:0002246) inflammatory response to wounding(GO:0090594) |
1.0 |
5.8 |
GO:0006196 |
AMP catabolic process(GO:0006196) |
1.0 |
4.8 |
GO:0051891 |
positive regulation of cardioblast differentiation(GO:0051891) positive regulation of cardiocyte differentiation(GO:1905209) |
1.0 |
1.0 |
GO:0010470 |
regulation of gastrulation(GO:0010470) |
0.9 |
5.6 |
GO:0060219 |
camera-type eye photoreceptor cell differentiation(GO:0060219) |
0.9 |
4.7 |
GO:0032488 |
Cdc42 protein signal transduction(GO:0032488) |
0.9 |
7.5 |
GO:1902668 |
negative regulation of axon guidance(GO:1902668) |
0.9 |
3.7 |
GO:0046121 |
deoxyribonucleoside catabolic process(GO:0046121) |
0.9 |
10.3 |
GO:0007216 |
G-protein coupled glutamate receptor signaling pathway(GO:0007216) |
0.9 |
1.9 |
GO:1903519 |
apoptotic process involved in mammary gland involution(GO:0060057) positive regulation of apoptotic process involved in mammary gland involution(GO:0060058) positive regulation of apoptotic process involved in morphogenesis(GO:1902339) regulation of mammary gland involution(GO:1903519) positive regulation of mammary gland involution(GO:1903521) positive regulation of apoptotic process involved in development(GO:1904747) |
0.9 |
6.5 |
GO:0006896 |
Golgi to endosome transport(GO:0006895) Golgi to vacuole transport(GO:0006896) |
0.9 |
7.4 |
GO:0002335 |
mature B cell differentiation(GO:0002335) |
0.9 |
9.2 |
GO:0051014 |
actin filament severing(GO:0051014) |
0.9 |
0.9 |
GO:0034244 |
negative regulation of DNA-templated transcription, elongation(GO:0032785) negative regulation of transcription elongation from RNA polymerase II promoter(GO:0034244) |
0.9 |
2.7 |
GO:0034616 |
response to laminar fluid shear stress(GO:0034616) |
0.9 |
0.9 |
GO:0014002 |
astrocyte development(GO:0014002) |
0.9 |
4.5 |
GO:0090343 |
positive regulation of cell aging(GO:0090343) |
0.9 |
2.7 |
GO:0006382 |
adenosine to inosine editing(GO:0006382) |
0.9 |
0.9 |
GO:0034447 |
very-low-density lipoprotein particle clearance(GO:0034447) |
0.9 |
8.1 |
GO:0006685 |
sphingomyelin catabolic process(GO:0006685) |
0.9 |
2.7 |
GO:0046208 |
spermine catabolic process(GO:0046208) |
0.9 |
24.8 |
GO:0031581 |
hemidesmosome assembly(GO:0031581) |
0.9 |
2.6 |
GO:2000121 |
regulation of removal of superoxide radicals(GO:2000121) |
0.9 |
4.3 |
GO:0018125 |
peptidyl-cysteine methylation(GO:0018125) |
0.9 |
2.6 |
GO:0032509 |
endosome transport via multivesicular body sorting pathway(GO:0032509) endosome to lysosome transport via multivesicular body sorting pathway(GO:0032510) |
0.9 |
6.0 |
GO:0060414 |
aorta development(GO:0035904) aorta morphogenesis(GO:0035909) aorta smooth muscle tissue morphogenesis(GO:0060414) |
0.9 |
1.7 |
GO:0035624 |
receptor transactivation(GO:0035624) epidermal growth factor-activated receptor transactivation by G-protein coupled receptor signaling pathway(GO:0035625) |
0.9 |
1.7 |
GO:0002072 |
optic cup morphogenesis involved in camera-type eye development(GO:0002072) |
0.9 |
6.0 |
GO:0022417 |
protein maturation by protein folding(GO:0022417) |
0.9 |
3.4 |
GO:0006701 |
progesterone biosynthetic process(GO:0006701) |
0.8 |
1.7 |
GO:0003197 |
endocardial cushion development(GO:0003197) |
0.8 |
3.4 |
GO:0042986 |
positive regulation of amyloid precursor protein biosynthetic process(GO:0042986) |
0.8 |
2.5 |
GO:0006307 |
DNA dealkylation involved in DNA repair(GO:0006307) DNA dealkylation(GO:0035510) |
0.8 |
5.9 |
GO:0015904 |
tetracycline transport(GO:0015904) |
0.8 |
4.1 |
GO:1903008 |
organelle disassembly(GO:1903008) |
0.8 |
4.1 |
GO:0019255 |
glucose 1-phosphate metabolic process(GO:0019255) |
0.8 |
4.1 |
GO:0070884 |
calcineurin-NFAT signaling cascade(GO:0033173) regulation of calcineurin-NFAT signaling cascade(GO:0070884) |
0.8 |
0.8 |
GO:0060157 |
urinary bladder development(GO:0060157) |
0.8 |
4.0 |
GO:0045989 |
positive regulation of striated muscle contraction(GO:0045989) |
0.8 |
4.0 |
GO:2000050 |
regulation of non-canonical Wnt signaling pathway(GO:2000050) |
0.8 |
6.4 |
GO:0010737 |
protein kinase A signaling(GO:0010737) regulation of protein kinase A signaling(GO:0010738) positive regulation of protein kinase A signaling(GO:0010739) |
0.8 |
2.4 |
GO:0002514 |
B cell tolerance induction(GO:0002514) regulation of B cell tolerance induction(GO:0002661) positive regulation of B cell tolerance induction(GO:0002663) |
0.8 |
2.4 |
GO:0006478 |
peptidyl-tyrosine sulfation(GO:0006478) |
0.8 |
3.9 |
GO:0007184 |
SMAD protein import into nucleus(GO:0007184) |
0.8 |
4.7 |
GO:0010799 |
regulation of peptidyl-threonine phosphorylation(GO:0010799) positive regulation of peptidyl-threonine phosphorylation(GO:0010800) |
0.8 |
0.8 |
GO:0002052 |
positive regulation of neuroblast proliferation(GO:0002052) |
0.8 |
3.1 |
GO:0060347 |
heart trabecula formation(GO:0060347) heart trabecula morphogenesis(GO:0061384) |
0.8 |
4.5 |
GO:0016264 |
gap junction assembly(GO:0016264) |
0.7 |
1.5 |
GO:0048668 |
collateral sprouting(GO:0048668) |
0.7 |
3.0 |
GO:0008347 |
glial cell migration(GO:0008347) |
0.7 |
1.5 |
GO:0033619 |
membrane protein proteolysis(GO:0033619) |
0.7 |
3.6 |
GO:0050932 |
regulation of melanocyte differentiation(GO:0045634) regulation of pigment cell differentiation(GO:0050932) |
0.7 |
1.5 |
GO:0090047 |
obsolete positive regulation of transcription regulator activity(GO:0090047) |
0.7 |
7.3 |
GO:0090292 |
nuclear matrix organization(GO:0043578) nuclear matrix anchoring at nuclear membrane(GO:0090292) |
0.7 |
3.6 |
GO:0042159 |
lipoprotein catabolic process(GO:0042159) |
0.7 |
2.9 |
GO:0015910 |
peroxisomal long-chain fatty acid import(GO:0015910) |
0.7 |
1.4 |
GO:1903020 |
positive regulation of glycoprotein biosynthetic process(GO:0010560) positive regulation of glycoprotein metabolic process(GO:1903020) |
0.7 |
2.1 |
GO:0007175 |
negative regulation of epidermal growth factor-activated receptor activity(GO:0007175) negative regulation of receptor activity(GO:2000272) |
0.7 |
2.8 |
GO:0007221 |
positive regulation of transcription of Notch receptor target(GO:0007221) |
0.7 |
9.8 |
GO:0043536 |
positive regulation of blood vessel endothelial cell migration(GO:0043536) |
0.7 |
2.8 |
GO:0051124 |
synaptic growth at neuromuscular junction(GO:0051124) |
0.7 |
0.7 |
GO:0050965 |
detection of temperature stimulus(GO:0016048) detection of temperature stimulus involved in sensory perception(GO:0050961) detection of temperature stimulus involved in sensory perception of pain(GO:0050965) |
0.7 |
2.7 |
GO:0000394 |
RNA splicing, via endonucleolytic cleavage and ligation(GO:0000394) tRNA splicing, via endonucleolytic cleavage and ligation(GO:0006388) |
0.7 |
2.1 |
GO:0048549 |
positive regulation of pinocytosis(GO:0048549) |
0.7 |
4.1 |
GO:0043268 |
positive regulation of potassium ion transport(GO:0043268) |
0.7 |
2.0 |
GO:0006740 |
NADPH regeneration(GO:0006740) |
0.7 |
2.0 |
GO:0007614 |
short-term memory(GO:0007614) |
0.7 |
2.7 |
GO:0001710 |
mesodermal cell fate commitment(GO:0001710) |
0.7 |
2.0 |
GO:0014742 |
positive regulation of cardiac muscle hypertrophy(GO:0010613) positive regulation of muscle hypertrophy(GO:0014742) leukemia inhibitory factor signaling pathway(GO:0048861) |
0.7 |
0.7 |
GO:0051897 |
regulation of protein kinase B signaling(GO:0051896) positive regulation of protein kinase B signaling(GO:0051897) |
0.7 |
2.0 |
GO:0090086 |
negative regulation of protein deubiquitination(GO:0090086) |
0.7 |
2.7 |
GO:0050703 |
interleukin-1 alpha secretion(GO:0050703) |
0.7 |
2.0 |
GO:0045662 |
negative regulation of myoblast differentiation(GO:0045662) |
0.7 |
5.2 |
GO:0010658 |
striated muscle cell apoptotic process(GO:0010658) cardiac muscle cell apoptotic process(GO:0010659) regulation of striated muscle cell apoptotic process(GO:0010662) negative regulation of striated muscle cell apoptotic process(GO:0010664) regulation of cardiac muscle cell apoptotic process(GO:0010665) negative regulation of cardiac muscle cell apoptotic process(GO:0010667) |
0.7 |
3.9 |
GO:0051927 |
obsolete negative regulation of calcium ion transport via voltage-gated calcium channel activity(GO:0051927) |
0.6 |
71.7 |
GO:0008154 |
actin polymerization or depolymerization(GO:0008154) |
0.6 |
3.2 |
GO:0009756 |
carbohydrate mediated signaling(GO:0009756) |
0.6 |
3.2 |
GO:0010561 |
negative regulation of glycoprotein biosynthetic process(GO:0010561) |
0.6 |
0.6 |
GO:0002675 |
positive regulation of acute inflammatory response(GO:0002675) |
0.6 |
3.8 |
GO:0032460 |
negative regulation of protein oligomerization(GO:0032460) negative regulation of protein homooligomerization(GO:0032463) |
0.6 |
1.9 |
GO:0007182 |
common-partner SMAD protein phosphorylation(GO:0007182) |
0.6 |
1.3 |
GO:0021592 |
fourth ventricle development(GO:0021592) |
0.6 |
1.3 |
GO:0045722 |
positive regulation of gluconeogenesis(GO:0045722) |
0.6 |
0.6 |
GO:0019673 |
GDP-mannose metabolic process(GO:0019673) |
0.6 |
1.3 |
GO:0010829 |
negative regulation of glucose transport(GO:0010829) negative regulation of glucose import(GO:0046325) |
0.6 |
1.2 |
GO:0070544 |
histone H3-K36 demethylation(GO:0070544) |
0.6 |
4.4 |
GO:0016255 |
attachment of GPI anchor to protein(GO:0016255) |
0.6 |
0.6 |
GO:0001865 |
NK T cell differentiation(GO:0001865) regulation of NK T cell differentiation(GO:0051136) positive regulation of NK T cell differentiation(GO:0051138) |
0.6 |
1.8 |
GO:0014063 |
regulation of serotonin secretion(GO:0014062) negative regulation of serotonin secretion(GO:0014063) |
0.6 |
3.7 |
GO:0032148 |
activation of protein kinase B activity(GO:0032148) |
0.6 |
1.8 |
GO:0016601 |
Rac protein signal transduction(GO:0016601) |
0.6 |
4.2 |
GO:0042249 |
establishment of planar polarity of embryonic epithelium(GO:0042249) |
0.6 |
1.8 |
GO:0060689 |
cell differentiation involved in salivary gland development(GO:0060689) |
0.6 |
1.2 |
GO:0046022 |
regulation of transcription from RNA polymerase II promoter, mitotic(GO:0046021) positive regulation of transcription from RNA polymerase II promoter during mitosis(GO:0046022) |
0.6 |
1.2 |
GO:0050765 |
negative regulation of phagocytosis(GO:0050765) |
0.6 |
1.8 |
GO:0061302 |
smooth muscle cell-matrix adhesion(GO:0061302) |
0.6 |
5.8 |
GO:0045600 |
positive regulation of fat cell differentiation(GO:0045600) |
0.6 |
1.8 |
GO:0071374 |
cellular response to parathyroid hormone stimulus(GO:0071374) |
0.6 |
2.9 |
GO:0014012 |
peripheral nervous system axon regeneration(GO:0014012) |
0.6 |
3.5 |
GO:0060056 |
mammary gland involution(GO:0060056) |
0.6 |
0.6 |
GO:0018106 |
peptidyl-histidine phosphorylation(GO:0018106) |
0.6 |
1.7 |
GO:0016476 |
regulation of embryonic cell shape(GO:0016476) |
0.6 |
9.1 |
GO:0030514 |
negative regulation of BMP signaling pathway(GO:0030514) |
0.6 |
2.3 |
GO:0032288 |
myelin assembly(GO:0032288) |
0.6 |
0.6 |
GO:0043046 |
DNA methylation involved in gamete generation(GO:0043046) |
0.6 |
0.6 |
GO:0055007 |
cardiac muscle cell differentiation(GO:0055007) |
0.6 |
2.3 |
GO:0006998 |
nuclear envelope organization(GO:0006998) |
0.6 |
4.5 |
GO:0007252 |
I-kappaB phosphorylation(GO:0007252) |
0.6 |
7.9 |
GO:0000052 |
citrulline metabolic process(GO:0000052) |
0.6 |
7.3 |
GO:0008045 |
motor neuron axon guidance(GO:0008045) |
0.6 |
1.1 |
GO:0010837 |
regulation of keratinocyte proliferation(GO:0010837) |
0.6 |
16.9 |
GO:0007045 |
cell-substrate adherens junction assembly(GO:0007045) focal adhesion assembly(GO:0048041) |
0.6 |
4.5 |
GO:1904893 |
negative regulation of JAK-STAT cascade(GO:0046426) negative regulation of STAT cascade(GO:1904893) |
0.6 |
1.7 |
GO:0010902 |
positive regulation of very-low-density lipoprotein particle remodeling(GO:0010902) positive regulation of phospholipid catabolic process(GO:0060697) |
0.6 |
0.6 |
GO:0050968 |
detection of chemical stimulus involved in sensory perception of pain(GO:0050968) |
0.6 |
18.8 |
GO:0018149 |
peptide cross-linking(GO:0018149) |
0.6 |
1.7 |
GO:0030517 |
negative regulation of axon extension(GO:0030517) |
0.5 |
1.1 |
GO:0031133 |
regulation of axon diameter(GO:0031133) regulation of cell projection size(GO:0032536) |
0.5 |
7.5 |
GO:0032456 |
endocytic recycling(GO:0032456) |
0.5 |
1.6 |
GO:0048010 |
vascular endothelial growth factor receptor signaling pathway(GO:0048010) |
0.5 |
4.3 |
GO:0006013 |
mannose metabolic process(GO:0006013) |
0.5 |
2.1 |
GO:0015891 |
iron chelate transport(GO:0015688) siderophore transport(GO:0015891) |
0.5 |
1.1 |
GO:0032367 |
intracellular sterol transport(GO:0032366) intracellular cholesterol transport(GO:0032367) |
0.5 |
1.6 |
GO:0018095 |
protein polyglutamylation(GO:0018095) |
0.5 |
2.1 |
GO:0051057 |
positive regulation of small GTPase mediated signal transduction(GO:0051057) |
0.5 |
5.8 |
GO:0098927 |
early endosome to late endosome transport(GO:0045022) vesicle-mediated transport between endosomal compartments(GO:0098927) |
0.5 |
1.0 |
GO:0090049 |
regulation of cell migration involved in sprouting angiogenesis(GO:0090049) regulation of sprouting angiogenesis(GO:1903670) |
0.5 |
0.5 |
GO:0043113 |
receptor clustering(GO:0043113) |
0.5 |
5.2 |
GO:0051938 |
L-glutamate import(GO:0051938) |
0.5 |
1.6 |
GO:0051797 |
regulation of hair follicle development(GO:0051797) |
0.5 |
1.6 |
GO:0032026 |
response to magnesium ion(GO:0032026) |
0.5 |
4.7 |
GO:0002011 |
morphogenesis of an epithelial sheet(GO:0002011) |
0.5 |
3.1 |
GO:0032472 |
cellular manganese ion homeostasis(GO:0030026) Golgi calcium ion homeostasis(GO:0032468) Golgi calcium ion transport(GO:0032472) manganese ion homeostasis(GO:0055071) |
0.5 |
1.5 |
GO:0061188 |
regulation of chromatin silencing at rDNA(GO:0061187) negative regulation of chromatin silencing at rDNA(GO:0061188) |
0.5 |
0.5 |
GO:0048048 |
embryonic eye morphogenesis(GO:0048048) |
0.5 |
1.5 |
GO:0009153 |
purine deoxyribonucleotide biosynthetic process(GO:0009153) |
0.5 |
4.1 |
GO:0030204 |
chondroitin sulfate metabolic process(GO:0030204) |
0.5 |
2.1 |
GO:0045652 |
regulation of megakaryocyte differentiation(GO:0045652) regulation of hematopoietic progenitor cell differentiation(GO:1901532) |
0.5 |
0.5 |
GO:0010544 |
negative regulation of platelet activation(GO:0010544) |
0.5 |
1.5 |
GO:0006543 |
glutamine catabolic process(GO:0006543) |
0.5 |
1.5 |
GO:0060279 |
regulation of ovulation(GO:0060278) positive regulation of ovulation(GO:0060279) |
0.5 |
3.0 |
GO:0034063 |
stress granule assembly(GO:0034063) |
0.5 |
1.0 |
GO:0014887 |
muscle hypertrophy in response to stress(GO:0003299) cardiac muscle adaptation(GO:0014887) cardiac muscle hypertrophy in response to stress(GO:0014898) |
0.5 |
2.0 |
GO:0050653 |
chondroitin sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0050653) |
0.5 |
0.5 |
GO:0007403 |
glial cell fate determination(GO:0007403) |
0.5 |
4.0 |
GO:0034260 |
negative regulation of GTPase activity(GO:0034260) |
0.5 |
10.9 |
GO:0042346 |
positive regulation of NF-kappaB import into nucleus(GO:0042346) |
0.5 |
2.0 |
GO:0001661 |
conditioned taste aversion(GO:0001661) |
0.5 |
1.0 |
GO:0007231 |
osmosensory signaling pathway(GO:0007231) |
0.5 |
1.0 |
GO:0010761 |
fibroblast migration(GO:0010761) |
0.5 |
1.0 |
GO:0090598 |
male genitalia morphogenesis(GO:0048808) male anatomical structure morphogenesis(GO:0090598) |
0.5 |
0.5 |
GO:0002686 |
negative regulation of leukocyte migration(GO:0002686) |
0.5 |
1.5 |
GO:0008065 |
establishment of blood-nerve barrier(GO:0008065) |
0.5 |
2.4 |
GO:0055003 |
cardiac myofibril assembly(GO:0055003) |
0.5 |
4.8 |
GO:0007172 |
signal complex assembly(GO:0007172) |
0.5 |
1.4 |
GO:0043012 |
regulation of fusion of sperm to egg plasma membrane(GO:0043012) |
0.5 |
0.5 |
GO:0030812 |
negative regulation of nucleotide catabolic process(GO:0030812) negative regulation of nucleoside metabolic process(GO:0045978) negative regulation of ATP metabolic process(GO:1903579) |
0.5 |
0.5 |
GO:0060993 |
kidney morphogenesis(GO:0060993) |
0.5 |
2.4 |
GO:0008354 |
germ cell migration(GO:0008354) |
0.5 |
1.9 |
GO:0071692 |
sequestering of extracellular ligand from receptor(GO:0035581) sequestering of TGFbeta in extracellular matrix(GO:0035583) protein localization to extracellular region(GO:0071692) maintenance of protein location in extracellular region(GO:0071694) extracellular regulation of signal transduction(GO:1900115) extracellular negative regulation of signal transduction(GO:1900116) |
0.5 |
3.3 |
GO:0048149 |
behavioral response to ethanol(GO:0048149) |
0.5 |
2.4 |
GO:0007183 |
SMAD protein complex assembly(GO:0007183) |
0.5 |
3.8 |
GO:0009650 |
UV protection(GO:0009650) |
0.5 |
7.6 |
GO:0018214 |
peptidyl-glutamic acid carboxylation(GO:0017187) protein carboxylation(GO:0018214) |
0.5 |
2.4 |
GO:0010759 |
regulation of macrophage chemotaxis(GO:0010758) positive regulation of macrophage chemotaxis(GO:0010759) mononuclear cell migration(GO:0071674) regulation of mononuclear cell migration(GO:0071675) |
0.5 |
1.9 |
GO:0060762 |
regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
0.5 |
0.9 |
GO:0032007 |
negative regulation of TOR signaling(GO:0032007) |
0.5 |
0.9 |
GO:0036072 |
intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
0.5 |
1.8 |
GO:0009956 |
radial pattern formation(GO:0009956) |
0.5 |
6.4 |
GO:0046324 |
regulation of glucose import(GO:0046324) |
0.5 |
1.4 |
GO:0050917 |
sensory perception of umami taste(GO:0050917) |
0.5 |
4.6 |
GO:0032964 |
collagen biosynthetic process(GO:0032964) |
0.5 |
1.8 |
GO:0034959 |
neuropeptide catabolic process(GO:0010813) substance P catabolic process(GO:0010814) calcitonin catabolic process(GO:0010816) endothelin maturation(GO:0034959) |
0.4 |
0.9 |
GO:0042761 |
very long-chain fatty acid biosynthetic process(GO:0042761) |
0.4 |
1.3 |
GO:0032429 |
regulation of phospholipase A2 activity(GO:0032429) |
0.4 |
1.3 |
GO:0016322 |
neuron remodeling(GO:0016322) |
0.4 |
2.6 |
GO:0018345 |
protein palmitoylation(GO:0018345) |
0.4 |
3.5 |
GO:0045843 |
negative regulation of striated muscle tissue development(GO:0045843) negative regulation of muscle tissue development(GO:1901862) |
0.4 |
0.4 |
GO:0060318 |
definitive erythrocyte differentiation(GO:0060318) |
0.4 |
2.6 |
GO:0060710 |
chorio-allantoic fusion(GO:0060710) |
0.4 |
3.5 |
GO:0046697 |
decidualization(GO:0046697) |
0.4 |
0.4 |
GO:0032878 |
regulation of establishment or maintenance of cell polarity(GO:0032878) |
0.4 |
6.0 |
GO:0048008 |
platelet-derived growth factor receptor signaling pathway(GO:0048008) |
0.4 |
2.1 |
GO:0008054 |
negative regulation of cyclin-dependent protein serine/threonine kinase by cyclin degradation(GO:0008054) |
0.4 |
4.2 |
GO:0090630 |
activation of GTPase activity(GO:0090630) |
0.4 |
0.4 |
GO:0060061 |
Spemann organizer formation(GO:0060061) |
0.4 |
4.2 |
GO:0006621 |
protein retention in ER lumen(GO:0006621) maintenance of protein localization in endoplasmic reticulum(GO:0035437) |
0.4 |
2.9 |
GO:0007185 |
transmembrane receptor protein tyrosine phosphatase signaling pathway(GO:0007185) |
0.4 |
0.8 |
GO:0060317 |
cardiac epithelial to mesenchymal transition(GO:0060317) |
0.4 |
1.2 |
GO:0034394 |
protein localization to cell surface(GO:0034394) |
0.4 |
31.5 |
GO:0008360 |
regulation of cell shape(GO:0008360) |
0.4 |
0.8 |
GO:0032227 |
negative regulation of synaptic transmission, dopaminergic(GO:0032227) |
0.4 |
2.5 |
GO:0030186 |
melatonin metabolic process(GO:0030186) melatonin biosynthetic process(GO:0030187) |
0.4 |
2.1 |
GO:0048148 |
behavioral response to cocaine(GO:0048148) |
0.4 |
0.8 |
GO:0048199 |
vesicle targeting, to, from or within Golgi(GO:0048199) |
0.4 |
4.0 |
GO:0042749 |
circadian sleep/wake cycle process(GO:0022410) regulation of circadian sleep/wake cycle(GO:0042749) regulation of circadian sleep/wake cycle, sleep(GO:0045187) circadian sleep/wake cycle, sleep(GO:0050802) |
0.4 |
23.0 |
GO:0017148 |
negative regulation of translation(GO:0017148) |
0.4 |
6.4 |
GO:0048207 |
vesicle targeting, rough ER to cis-Golgi(GO:0048207) COPII vesicle coating(GO:0048208) COPII-coated vesicle budding(GO:0090114) |
0.4 |
12.0 |
GO:0015914 |
phospholipid transport(GO:0015914) |
0.4 |
1.2 |
GO:0071529 |
cementum mineralization(GO:0071529) |
0.4 |
2.4 |
GO:0048488 |
synaptic vesicle recycling(GO:0036465) synaptic vesicle endocytosis(GO:0048488) clathrin-mediated endocytosis(GO:0072583) |
0.4 |
12.7 |
GO:0034332 |
adherens junction organization(GO:0034332) |
0.4 |
2.0 |
GO:0042517 |
positive regulation of tyrosine phosphorylation of Stat3 protein(GO:0042517) |
0.4 |
2.7 |
GO:0045408 |
regulation of interleukin-6 biosynthetic process(GO:0045408) |
0.4 |
1.9 |
GO:1901881 |
positive regulation of protein depolymerization(GO:1901881) |
0.4 |
1.2 |
GO:0070120 |
ciliary neurotrophic factor-mediated signaling pathway(GO:0070120) |
0.4 |
0.8 |
GO:0030205 |
dermatan sulfate metabolic process(GO:0030205) dermatan sulfate biosynthetic process(GO:0030208) |
0.4 |
0.8 |
GO:0007028 |
cytoplasm organization(GO:0007028) |
0.4 |
1.5 |
GO:0033688 |
regulation of osteoblast proliferation(GO:0033688) |
0.4 |
1.9 |
GO:0005981 |
regulation of glycogen catabolic process(GO:0005981) |
0.4 |
0.8 |
GO:0060457 |
negative regulation of digestive system process(GO:0060457) |
0.4 |
0.4 |
GO:1900087 |
traversing start control point of mitotic cell cycle(GO:0007089) positive regulation of G1/S transition of mitotic cell cycle(GO:1900087) positive regulation of cell cycle G1/S phase transition(GO:1902808) |
0.4 |
2.6 |
GO:0002040 |
sprouting angiogenesis(GO:0002040) |
0.4 |
10.1 |
GO:0050772 |
positive regulation of axonogenesis(GO:0050772) |
0.4 |
1.1 |
GO:0008298 |
intracellular mRNA localization(GO:0008298) |
0.4 |
1.1 |
GO:0051451 |
myoblast migration(GO:0051451) |
0.4 |
0.7 |
GO:0060159 |
regulation of dopamine receptor signaling pathway(GO:0060159) positive regulation of dopamine receptor signaling pathway(GO:0060161) |
0.4 |
2.2 |
GO:0010766 |
negative regulation of sodium ion transport(GO:0010766) |
0.4 |
0.4 |
GO:0010507 |
negative regulation of autophagy(GO:0010507) |
0.4 |
33.7 |
GO:0035023 |
regulation of Rho protein signal transduction(GO:0035023) |
0.4 |
5.1 |
GO:1901224 |
activation of NF-kappaB-inducing kinase activity(GO:0007250) NIK/NF-kappaB signaling(GO:0038061) regulation of NIK/NF-kappaB signaling(GO:1901222) positive regulation of NIK/NF-kappaB signaling(GO:1901224) |
0.4 |
9.1 |
GO:0007041 |
lysosomal transport(GO:0007041) |
0.4 |
1.1 |
GO:0002885 |
positive regulation of hypersensitivity(GO:0002885) |
0.4 |
1.4 |
GO:0006434 |
seryl-tRNA aminoacylation(GO:0006434) |
0.4 |
6.4 |
GO:0006023 |
aminoglycan biosynthetic process(GO:0006023) |
0.4 |
9.2 |
GO:0030865 |
cortical cytoskeleton organization(GO:0030865) |
0.4 |
0.7 |
GO:0006982 |
response to lipid hydroperoxide(GO:0006982) |
0.4 |
0.4 |
GO:0019530 |
taurine metabolic process(GO:0019530) |
0.4 |
0.4 |
GO:0019369 |
arachidonic acid metabolic process(GO:0019369) |
0.4 |
1.1 |
GO:0071392 |
cellular response to estradiol stimulus(GO:0071392) |
0.4 |
0.7 |
GO:0060037 |
pharyngeal system development(GO:0060037) |
0.4 |
0.4 |
GO:0001993 |
regulation of systemic arterial blood pressure by norepinephrine-epinephrine(GO:0001993) |
0.4 |
2.1 |
GO:0035335 |
peptidyl-tyrosine dephosphorylation(GO:0035335) |
0.3 |
1.4 |
GO:0019046 |
release from viral latency(GO:0019046) |
0.3 |
14.6 |
GO:0007519 |
skeletal muscle tissue development(GO:0007519) skeletal muscle organ development(GO:0060538) |
0.3 |
3.5 |
GO:0061037 |
negative regulation of chondrocyte differentiation(GO:0032331) negative regulation of cartilage development(GO:0061037) |
0.3 |
1.4 |
GO:0043441 |
acetoacetic acid biosynthetic process(GO:0043441) |
0.3 |
1.0 |
GO:0014047 |
glutamate secretion(GO:0014047) |
0.3 |
1.0 |
GO:0030091 |
protein repair(GO:0030091) |
0.3 |
2.1 |
GO:0071445 |
obsolete cellular response to protein stimulus(GO:0071445) |
0.3 |
0.7 |
GO:0050685 |
positive regulation of mRNA 3'-end processing(GO:0031442) positive regulation of mRNA processing(GO:0050685) positive regulation of mRNA metabolic process(GO:1903313) |
0.3 |
1.4 |
GO:0001878 |
response to yeast(GO:0001878) |
0.3 |
7.5 |
GO:0007613 |
memory(GO:0007613) |
0.3 |
23.7 |
GO:0030198 |
extracellular matrix organization(GO:0030198) extracellular structure organization(GO:0043062) |
0.3 |
2.4 |
GO:0055093 |
response to increased oxygen levels(GO:0036296) response to hyperoxia(GO:0055093) |
0.3 |
3.0 |
GO:0007176 |
regulation of epidermal growth factor-activated receptor activity(GO:0007176) |
0.3 |
4.4 |
GO:0006911 |
phagocytosis, engulfment(GO:0006911) membrane invagination(GO:0010324) |
0.3 |
1.0 |
GO:0006007 |
glucose catabolic process(GO:0006007) |
0.3 |
1.3 |
GO:0046855 |
phosphorylated carbohydrate dephosphorylation(GO:0046838) inositol phosphate dephosphorylation(GO:0046855) |
0.3 |
3.6 |
GO:0030520 |
intracellular estrogen receptor signaling pathway(GO:0030520) |
0.3 |
0.7 |
GO:0046541 |
saliva secretion(GO:0046541) |
0.3 |
0.7 |
GO:0051149 |
positive regulation of muscle cell differentiation(GO:0051149) |
0.3 |
1.0 |
GO:0006051 |
mannosamine metabolic process(GO:0006050) N-acetylmannosamine metabolic process(GO:0006051) |
0.3 |
0.3 |
GO:0031065 |
positive regulation of histone deacetylation(GO:0031065) |
0.3 |
1.9 |
GO:0006562 |
proline catabolic process(GO:0006562) |
0.3 |
3.2 |
GO:0051496 |
positive regulation of stress fiber assembly(GO:0051496) |
0.3 |
1.9 |
GO:0043415 |
positive regulation of skeletal muscle tissue regeneration(GO:0043415) regulation of skeletal muscle tissue regeneration(GO:0043416) |
0.3 |
2.5 |
GO:0035115 |
embryonic forelimb morphogenesis(GO:0035115) |
0.3 |
1.0 |
GO:0021520 |
spinal cord motor neuron cell fate specification(GO:0021520) |
0.3 |
1.9 |
GO:0051005 |
negative regulation of lipoprotein lipase activity(GO:0051005) |
0.3 |
1.6 |
GO:0046349 |
UDP-N-acetylglucosamine biosynthetic process(GO:0006048) amino sugar biosynthetic process(GO:0046349) |
0.3 |
0.9 |
GO:0071277 |
cellular response to calcium ion(GO:0071277) |
0.3 |
0.9 |
GO:1904358 |
positive regulation of telomere maintenance via telomerase(GO:0032212) positive regulation of telomere maintenance via telomere lengthening(GO:1904358) |
0.3 |
0.6 |
GO:0070306 |
lens fiber cell differentiation(GO:0070306) |
0.3 |
0.3 |
GO:0045618 |
positive regulation of keratinocyte differentiation(GO:0045618) |
0.3 |
3.7 |
GO:0007263 |
nitric oxide mediated signal transduction(GO:0007263) |
0.3 |
0.9 |
GO:0006004 |
fucose metabolic process(GO:0006004) |
0.3 |
5.8 |
GO:0000045 |
autophagosome assembly(GO:0000045) autophagosome organization(GO:1905037) |
0.3 |
3.6 |
GO:0051319 |
mitotic G2 phase(GO:0000085) G2 phase(GO:0051319) |
0.3 |
0.9 |
GO:0033578 |
protein glycosylation in Golgi(GO:0033578) |
0.3 |
0.6 |
GO:0030644 |
cellular chloride ion homeostasis(GO:0030644) chloride ion homeostasis(GO:0055064) |
0.3 |
4.8 |
GO:0008634 |
obsolete negative regulation of survival gene product expression(GO:0008634) |
0.3 |
1.5 |
GO:0046607 |
positive regulation of centrosome cycle(GO:0046607) |
0.3 |
0.9 |
GO:0014010 |
Schwann cell proliferation(GO:0014010) |
0.3 |
0.9 |
GO:0001885 |
endothelial cell development(GO:0001885) |
0.3 |
1.2 |
GO:0001945 |
lymph vessel development(GO:0001945) |
0.3 |
10.7 |
GO:0007193 |
adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway(GO:0007193) |
0.3 |
0.9 |
GO:0006880 |
intracellular sequestering of iron ion(GO:0006880) sequestering of iron ion(GO:0097577) |
0.3 |
0.9 |
GO:0045844 |
positive regulation of striated muscle tissue development(GO:0045844) positive regulation of muscle organ development(GO:0048636) positive regulation of muscle tissue development(GO:1901863) |
0.3 |
1.4 |
GO:0006295 |
nucleotide-excision repair, DNA incision, 3'-to lesion(GO:0006295) |
0.3 |
4.5 |
GO:0015697 |
quaternary ammonium group transport(GO:0015697) |
0.3 |
1.4 |
GO:0071108 |
protein K48-linked deubiquitination(GO:0071108) |
0.3 |
1.4 |
GO:0002517 |
T cell tolerance induction(GO:0002517) regulation of T cell tolerance induction(GO:0002664) positive regulation of T cell tolerance induction(GO:0002666) |
0.3 |
10.0 |
GO:0007266 |
Rho protein signal transduction(GO:0007266) |
0.3 |
0.3 |
GO:0032898 |
neurotrophin production(GO:0032898) |
0.3 |
4.9 |
GO:0046847 |
filopodium assembly(GO:0046847) |
0.3 |
0.8 |
GO:0060136 |
embryonic process involved in female pregnancy(GO:0060136) |
0.3 |
1.6 |
GO:0030853 |
negative regulation of granulocyte differentiation(GO:0030853) |
0.3 |
0.3 |
GO:0001936 |
regulation of endothelial cell proliferation(GO:0001936) |
0.3 |
1.9 |
GO:0006107 |
oxaloacetate metabolic process(GO:0006107) |
0.3 |
3.2 |
GO:0031532 |
actin cytoskeleton reorganization(GO:0031532) |
0.3 |
0.3 |
GO:0031338 |
regulation of vesicle fusion(GO:0031338) |
0.3 |
2.7 |
GO:0002347 |
response to tumor cell(GO:0002347) |
0.3 |
0.8 |
GO:0014066 |
regulation of phosphatidylinositol 3-kinase signaling(GO:0014066) |
0.3 |
0.3 |
GO:0019276 |
UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
0.3 |
1.3 |
GO:0071731 |
response to nitric oxide(GO:0071731) |
0.3 |
4.8 |
GO:0007157 |
heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0007157) |
0.3 |
1.9 |
GO:0031345 |
negative regulation of cell projection organization(GO:0031345) |
0.3 |
1.3 |
GO:0032516 |
positive regulation of phosphoprotein phosphatase activity(GO:0032516) |
0.3 |
0.3 |
GO:0051590 |
positive regulation of neurotransmitter transport(GO:0051590) |
0.3 |
0.8 |
GO:0045838 |
positive regulation of membrane potential(GO:0045838) |
0.3 |
1.1 |
GO:0009629 |
response to gravity(GO:0009629) |
0.3 |
0.8 |
GO:0050758 |
thymidylate synthase biosynthetic process(GO:0050757) regulation of thymidylate synthase biosynthetic process(GO:0050758) negative regulation of thymidylate synthase biosynthetic process(GO:0050760) |
0.3 |
0.5 |
GO:0032236 |
obsolete positive regulation of calcium ion transport via store-operated calcium channel activity(GO:0032236) |
0.3 |
0.5 |
GO:0001569 |
patterning of blood vessels(GO:0001569) |
0.3 |
1.6 |
GO:0002921 |
negative regulation of humoral immune response(GO:0002921) negative regulation of complement activation(GO:0045916) negative regulation of protein activation cascade(GO:2000258) |
0.3 |
5.2 |
GO:0048009 |
insulin-like growth factor receptor signaling pathway(GO:0048009) |
0.3 |
0.8 |
GO:0060012 |
synaptic transmission, glycinergic(GO:0060012) |
0.3 |
3.3 |
GO:0035036 |
binding of sperm to zona pellucida(GO:0007339) sperm-egg recognition(GO:0035036) |
0.3 |
0.8 |
GO:0042268 |
regulation of cytolysis(GO:0042268) |
0.3 |
1.0 |
GO:0050687 |
negative regulation of immune effector process(GO:0002698) negative regulation of defense response to virus(GO:0050687) |
0.3 |
23.0 |
GO:0031589 |
cell-substrate adhesion(GO:0031589) |
0.2 |
6.2 |
GO:0007015 |
actin filament organization(GO:0007015) |
0.2 |
0.2 |
GO:0048170 |
positive regulation of long-term neuronal synaptic plasticity(GO:0048170) |
0.2 |
29.0 |
GO:0043087 |
regulation of GTPase activity(GO:0043087) |
0.2 |
1.0 |
GO:0032922 |
circadian regulation of gene expression(GO:0032922) |
0.2 |
5.9 |
GO:0002474 |
antigen processing and presentation of peptide antigen via MHC class I(GO:0002474) |
0.2 |
8.3 |
GO:0007190 |
activation of adenylate cyclase activity(GO:0007190) |
0.2 |
4.4 |
GO:0031424 |
keratinization(GO:0031424) |
0.2 |
1.7 |
GO:0001881 |
receptor recycling(GO:0001881) |
0.2 |
0.2 |
GO:0072385 |
minus-end-directed organelle transport along microtubule(GO:0072385) |
0.2 |
6.0 |
GO:0030814 |
regulation of cAMP metabolic process(GO:0030814) |
0.2 |
0.7 |
GO:0046839 |
phospholipid dephosphorylation(GO:0046839) |
0.2 |
0.2 |
GO:0051898 |
negative regulation of protein kinase B signaling(GO:0051898) |
0.2 |
0.2 |
GO:0006651 |
diacylglycerol biosynthetic process(GO:0006651) |
0.2 |
14.8 |
GO:0045454 |
cell redox homeostasis(GO:0045454) |
0.2 |
0.7 |
GO:0006210 |
pyrimidine nucleobase catabolic process(GO:0006208) thymine catabolic process(GO:0006210) thymine metabolic process(GO:0019859) |
0.2 |
0.7 |
GO:0046341 |
CDP-diacylglycerol metabolic process(GO:0046341) |
0.2 |
4.5 |
GO:0043542 |
endothelial cell migration(GO:0043542) |
0.2 |
2.1 |
GO:1901678 |
iron coordination entity transport(GO:1901678) |
0.2 |
0.5 |
GO:0010107 |
potassium ion import(GO:0010107) |
0.2 |
17.7 |
GO:0034329 |
cell junction assembly(GO:0034329) |
0.2 |
0.7 |
GO:0033278 |
cell proliferation in midbrain(GO:0033278) |
0.2 |
3.0 |
GO:0070193 |
synaptonemal complex organization(GO:0070193) |
0.2 |
0.7 |
GO:0048638 |
regulation of developmental growth(GO:0048638) |
0.2 |
0.2 |
GO:0016101 |
retinoid metabolic process(GO:0001523) diterpenoid metabolic process(GO:0016101) |
0.2 |
0.7 |
GO:0061084 |
regulation of protein refolding(GO:0061083) negative regulation of protein refolding(GO:0061084) negative regulation of protein folding(GO:1903333) |
0.2 |
0.2 |
GO:0051877 |
pigment granule aggregation in cell center(GO:0051877) |
0.2 |
5.2 |
GO:0032963 |
collagen metabolic process(GO:0032963) |
0.2 |
0.9 |
GO:0035434 |
copper ion transmembrane transport(GO:0035434) |
0.2 |
0.2 |
GO:0072201 |
negative regulation of mesenchymal cell proliferation(GO:0072201) |
0.2 |
0.4 |
GO:0006537 |
glutamate biosynthetic process(GO:0006537) |
0.2 |
0.7 |
GO:0002378 |
immunoglobulin biosynthetic process(GO:0002378) protein O-linked glycosylation via serine(GO:0018242) protein O-linked glycosylation via threonine(GO:0018243) |
0.2 |
0.2 |
GO:0045920 |
negative regulation of exocytosis(GO:0045920) |
0.2 |
0.9 |
GO:0019321 |
pentose metabolic process(GO:0019321) |
0.2 |
2.9 |
GO:0030212 |
hyaluronan metabolic process(GO:0030212) |
0.2 |
5.7 |
GO:0043462 |
regulation of ATPase activity(GO:0043462) |
0.2 |
0.4 |
GO:0030856 |
regulation of epithelial cell differentiation(GO:0030856) |
0.2 |
0.2 |
GO:0043526 |
obsolete neuroprotection(GO:0043526) |
0.2 |
0.2 |
GO:0007413 |
axonal fasciculation(GO:0007413) |
0.2 |
0.6 |
GO:0034405 |
response to fluid shear stress(GO:0034405) |
0.2 |
1.3 |
GO:0007499 |
ectoderm and mesoderm interaction(GO:0007499) |
0.2 |
0.4 |
GO:0035120 |
post-embryonic appendage morphogenesis(GO:0035120) |
0.2 |
0.6 |
GO:0048263 |
determination of dorsal identity(GO:0048263) |
0.2 |
4.3 |
GO:0033540 |
fatty acid beta-oxidation using acyl-CoA oxidase(GO:0033540) |
0.2 |
0.9 |
GO:0017014 |
protein nitrosylation(GO:0017014) peptidyl-cysteine S-nitrosylation(GO:0018119) |
0.2 |
4.5 |
GO:0010633 |
negative regulation of epithelial cell migration(GO:0010633) |
0.2 |
1.7 |
GO:0006491 |
N-glycan processing(GO:0006491) |
0.2 |
1.5 |
GO:0016559 |
peroxisome fission(GO:0016559) |
0.2 |
1.0 |
GO:0021548 |
pons development(GO:0021548) |
0.2 |
0.8 |
GO:0042335 |
cuticle development(GO:0042335) |
0.2 |
2.5 |
GO:0048286 |
lung alveolus development(GO:0048286) |
0.2 |
1.2 |
GO:0046133 |
pyrimidine ribonucleoside catabolic process(GO:0046133) |
0.2 |
0.4 |
GO:0030997 |
regulation of centriole-centriole cohesion(GO:0030997) |
0.2 |
2.2 |
GO:0007340 |
acrosome reaction(GO:0007340) |
0.2 |
2.0 |
GO:0017121 |
phospholipid scrambling(GO:0017121) regulation of membrane lipid distribution(GO:0097035) |
0.2 |
0.6 |
GO:0007622 |
rhythmic behavior(GO:0007622) circadian sleep/wake cycle(GO:0042745) circadian behavior(GO:0048512) |
0.2 |
1.4 |
GO:0006613 |
cotranslational protein targeting to membrane(GO:0006613) |
0.2 |
7.2 |
GO:0030029 |
actin filament-based process(GO:0030029) |
0.2 |
0.6 |
GO:0046618 |
drug export(GO:0046618) |
0.2 |
1.6 |
GO:0006379 |
mRNA cleavage(GO:0006379) |
0.2 |
0.6 |
GO:0090084 |
negative regulation of inclusion body assembly(GO:0090084) |
0.2 |
0.4 |
GO:0018126 |
protein hydroxylation(GO:0018126) |
0.2 |
3.3 |
GO:0071772 |
BMP signaling pathway(GO:0030509) response to BMP(GO:0071772) cellular response to BMP stimulus(GO:0071773) |
0.2 |
1.0 |
GO:0043402 |
glucocorticoid mediated signaling pathway(GO:0043402) |
0.2 |
3.1 |
GO:0045768 |
obsolete positive regulation of anti-apoptosis(GO:0045768) |
0.2 |
2.3 |
GO:0042733 |
embryonic digit morphogenesis(GO:0042733) |
0.2 |
2.9 |
GO:0042246 |
tissue regeneration(GO:0042246) |
0.2 |
0.8 |
GO:0009301 |
snRNA transcription(GO:0009301) |
0.2 |
0.6 |
GO:0006530 |
asparagine catabolic process(GO:0006530) asparagine catabolic process via L-aspartate(GO:0033345) |
0.2 |
0.4 |
GO:0031529 |
ruffle organization(GO:0031529) |
0.2 |
0.7 |
GO:0051495 |
positive regulation of cytoskeleton organization(GO:0051495) |
0.2 |
1.8 |
GO:0006704 |
glucocorticoid biosynthetic process(GO:0006704) |
0.2 |
0.6 |
GO:0046210 |
nitric oxide catabolic process(GO:0046210) |
0.2 |
5.1 |
GO:0007229 |
integrin-mediated signaling pathway(GO:0007229) |
0.2 |
0.5 |
GO:0006423 |
cysteinyl-tRNA aminoacylation(GO:0006423) |
0.2 |
1.8 |
GO:0016236 |
macroautophagy(GO:0016236) |
0.2 |
0.7 |
GO:0090136 |
zonula adherens maintenance(GO:0045218) epithelial cell-cell adhesion(GO:0090136) |
0.2 |
0.4 |
GO:0071384 |
cellular response to corticosteroid stimulus(GO:0071384) cellular response to glucocorticoid stimulus(GO:0071385) |
0.2 |
0.4 |
GO:0035058 |
nonmotile primary cilium assembly(GO:0035058) |
0.2 |
1.9 |
GO:0007567 |
parturition(GO:0007567) |
0.2 |
0.7 |
GO:0032465 |
regulation of cytokinesis(GO:0032465) |
0.2 |
0.4 |
GO:0006890 |
retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
0.2 |
0.5 |
GO:0042727 |
flavin-containing compound metabolic process(GO:0042726) flavin-containing compound biosynthetic process(GO:0042727) |
0.2 |
0.3 |
GO:2000108 |
positive regulation of leukocyte apoptotic process(GO:2000108) |
0.2 |
0.7 |
GO:0006942 |
regulation of striated muscle contraction(GO:0006942) |
0.2 |
9.4 |
GO:0007588 |
excretion(GO:0007588) |
0.2 |
0.2 |
GO:0009051 |
pentose-phosphate shunt, oxidative branch(GO:0009051) |
0.2 |
38.5 |
GO:0006897 |
endocytosis(GO:0006897) |
0.2 |
3.9 |
GO:0045727 |
positive regulation of cellular amide metabolic process(GO:0034250) positive regulation of translation(GO:0045727) |
0.2 |
0.8 |
GO:0045071 |
negative regulation of viral genome replication(GO:0045071) |
0.2 |
1.3 |
GO:0006465 |
signal peptide processing(GO:0006465) |
0.2 |
2.9 |
GO:0000768 |
syncytium formation by plasma membrane fusion(GO:0000768) |
0.2 |
0.3 |
GO:1901031 |
regulation of cellular response to oxidative stress(GO:1900407) regulation of response to reactive oxygen species(GO:1901031) regulation of response to oxidative stress(GO:1902882) |
0.2 |
1.3 |
GO:0070972 |
protein localization to endoplasmic reticulum(GO:0070972) |
0.2 |
8.5 |
GO:0008277 |
regulation of G-protein coupled receptor protein signaling pathway(GO:0008277) |
0.2 |
0.8 |
GO:0007016 |
cytoskeletal anchoring at plasma membrane(GO:0007016) |
0.2 |
1.0 |
GO:0042420 |
dopamine catabolic process(GO:0042420) |
0.2 |
0.3 |
GO:0060405 |
regulation of penile erection(GO:0060405) |
0.2 |
0.3 |
GO:0046322 |
negative regulation of fatty acid oxidation(GO:0046322) |
0.2 |
1.3 |
GO:0034755 |
iron ion transmembrane transport(GO:0034755) |
0.2 |
3.9 |
GO:0007026 |
negative regulation of microtubule depolymerization(GO:0007026) |
0.2 |
0.6 |
GO:0048295 |
positive regulation of isotype switching to IgE isotypes(GO:0048295) |
0.2 |
0.5 |
GO:0006556 |
S-adenosylmethionine biosynthetic process(GO:0006556) |
0.2 |
1.1 |
GO:0045793 |
positive regulation of cell size(GO:0045793) |
0.2 |
0.2 |
GO:0070265 |
necrotic cell death(GO:0070265) |
0.2 |
3.4 |
GO:0016486 |
peptide hormone processing(GO:0016486) |
0.2 |
0.2 |
GO:0043270 |
positive regulation of ion transport(GO:0043270) |
0.2 |
0.5 |
GO:0034638 |
phosphatidylcholine catabolic process(GO:0034638) |
0.2 |
0.2 |
GO:0031017 |
exocrine pancreas development(GO:0031017) |
0.2 |
2.4 |
GO:0030216 |
keratinocyte differentiation(GO:0030216) |
0.2 |
0.2 |
GO:0060972 |
left/right pattern formation(GO:0060972) |
0.2 |
0.8 |
GO:0019852 |
L-ascorbic acid metabolic process(GO:0019852) |
0.2 |
0.9 |
GO:0006003 |
fructose 2,6-bisphosphate metabolic process(GO:0006003) |
0.2 |
0.2 |
GO:0033085 |
negative regulation of T cell differentiation in thymus(GO:0033085) negative regulation of thymocyte aggregation(GO:2000399) |
0.2 |
0.5 |
GO:0045948 |
positive regulation of translational initiation(GO:0045948) |
0.2 |
0.3 |
GO:1902117 |
positive regulation of organelle assembly(GO:1902117) |
0.2 |
0.6 |
GO:0000389 |
mRNA 3'-splice site recognition(GO:0000389) |
0.2 |
1.2 |
GO:0050732 |
negative regulation of peptidyl-tyrosine phosphorylation(GO:0050732) |
0.2 |
1.7 |
GO:0045161 |
neuronal ion channel clustering(GO:0045161) |
0.2 |
6.3 |
GO:0007623 |
circadian rhythm(GO:0007623) |
0.1 |
0.6 |
GO:0045598 |
regulation of fat cell differentiation(GO:0045598) |
0.1 |
0.6 |
GO:0051602 |
response to electrical stimulus(GO:0051602) |
0.1 |
0.4 |
GO:0051102 |
DNA ligation involved in DNA recombination(GO:0051102) |
0.1 |
0.4 |
GO:0045062 |
extrathymic T cell differentiation(GO:0033078) extrathymic T cell selection(GO:0045062) |
0.1 |
0.6 |
GO:0009109 |
coenzyme catabolic process(GO:0009109) |
0.1 |
2.8 |
GO:0018208 |
peptidyl-proline modification(GO:0018208) |
0.1 |
10.1 |
GO:0007179 |
transforming growth factor beta receptor signaling pathway(GO:0007179) |
0.1 |
0.3 |
GO:0034435 |
steroid esterification(GO:0034433) sterol esterification(GO:0034434) cholesterol esterification(GO:0034435) |
0.1 |
0.3 |
GO:0033145 |
positive regulation of intracellular steroid hormone receptor signaling pathway(GO:0033145) |
0.1 |
0.3 |
GO:0010332 |
response to gamma radiation(GO:0010332) |
0.1 |
4.2 |
GO:0032436 |
positive regulation of proteasomal ubiquitin-dependent protein catabolic process(GO:0032436) positive regulation of proteasomal protein catabolic process(GO:1901800) |
0.1 |
0.4 |
GO:0009642 |
response to light intensity(GO:0009642) |
0.1 |
0.3 |
GO:0014819 |
regulation of skeletal muscle contraction(GO:0014819) |
0.1 |
3.3 |
GO:0033572 |
ferric iron transport(GO:0015682) transferrin transport(GO:0033572) trivalent inorganic cation transport(GO:0072512) |
0.1 |
0.4 |
GO:0043586 |
tongue development(GO:0043586) |
0.1 |
1.1 |
GO:0045069 |
regulation of viral genome replication(GO:0045069) |
0.1 |
3.1 |
GO:0072164 |
ureteric bud development(GO:0001657) mesonephric epithelium development(GO:0072163) mesonephric tubule development(GO:0072164) |
0.1 |
0.5 |
GO:0034587 |
piRNA metabolic process(GO:0034587) |
0.1 |
0.4 |
GO:0001544 |
initiation of primordial ovarian follicle growth(GO:0001544) |
0.1 |
0.4 |
GO:0002124 |
aggressive behavior(GO:0002118) territorial aggressive behavior(GO:0002124) brainstem development(GO:0003360) vocalization behavior(GO:0071625) |
0.1 |
0.3 |
GO:0032222 |
regulation of synaptic transmission, cholinergic(GO:0032222) |
0.1 |
0.3 |
GO:0032119 |
sequestering of zinc ion(GO:0032119) regulation of sequestering of zinc ion(GO:0061088) |
0.1 |
0.5 |
GO:0071418 |
uroporphyrinogen III biosynthetic process(GO:0006780) cellular response to amine stimulus(GO:0071418) |
0.1 |
1.3 |
GO:0000038 |
very long-chain fatty acid metabolic process(GO:0000038) |
0.1 |
1.3 |
GO:0006612 |
protein targeting to membrane(GO:0006612) |
0.1 |
0.1 |
GO:0043266 |
regulation of potassium ion transport(GO:0043266) |
0.1 |
1.6 |
GO:0035967 |
cellular response to topologically incorrect protein(GO:0035967) |
0.1 |
0.5 |
GO:0009296 |
obsolete flagellum assembly(GO:0009296) |
0.1 |
1.7 |
GO:0048813 |
dendrite morphogenesis(GO:0048813) |
0.1 |
0.2 |
GO:0043162 |
ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
0.1 |
14.5 |
GO:0007517 |
muscle organ development(GO:0007517) |
0.1 |
0.9 |
GO:0007171 |
activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
0.1 |
0.2 |
GO:0045749 |
obsolete negative regulation of S phase of mitotic cell cycle(GO:0045749) |
0.1 |
0.1 |
GO:0010874 |
regulation of cholesterol efflux(GO:0010874) |
0.1 |
2.6 |
GO:0036503 |
ER-associated ubiquitin-dependent protein catabolic process(GO:0030433) ERAD pathway(GO:0036503) |
0.1 |
0.6 |
GO:0042149 |
cellular response to glucose starvation(GO:0042149) |
0.1 |
0.6 |
GO:0010976 |
positive regulation of neuron projection development(GO:0010976) |
0.1 |
12.3 |
GO:0016125 |
sterol metabolic process(GO:0016125) |
0.1 |
0.2 |
GO:0051901 |
positive regulation of mitochondrial depolarization(GO:0051901) positive regulation of membrane depolarization(GO:1904181) |
0.1 |
1.6 |
GO:0042059 |
negative regulation of epidermal growth factor receptor signaling pathway(GO:0042059) negative regulation of ERBB signaling pathway(GO:1901185) |
0.1 |
0.8 |
GO:0007528 |
neuromuscular junction development(GO:0007528) |
0.1 |
0.8 |
GO:0000301 |
retrograde transport, vesicle recycling within Golgi(GO:0000301) |
0.1 |
0.1 |
GO:0001880 |
Mullerian duct regression(GO:0001880) |
0.1 |
5.0 |
GO:0006958 |
complement activation, classical pathway(GO:0006958) |
0.1 |
0.7 |
GO:0045445 |
myoblast differentiation(GO:0045445) |
0.1 |
1.7 |
GO:0006071 |
glycerol metabolic process(GO:0006071) |
0.1 |
0.1 |
GO:0014048 |
regulation of glutamate secretion(GO:0014048) |
0.1 |
0.3 |
GO:0015871 |
choline transport(GO:0015871) |
0.1 |
0.8 |
GO:0015800 |
acidic amino acid transport(GO:0015800) |
0.1 |
0.1 |
GO:0070059 |
intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress(GO:0070059) |
0.1 |
2.5 |
GO:0006914 |
autophagy(GO:0006914) |
0.1 |
0.1 |
GO:0002901 |
mature B cell apoptotic process(GO:0002901) regulation of mature B cell apoptotic process(GO:0002905) negative regulation of mature B cell apoptotic process(GO:0002906) |
0.1 |
2.0 |
GO:0050818 |
regulation of coagulation(GO:0050818) |
0.1 |
0.6 |
GO:0019835 |
cytolysis(GO:0019835) |
0.1 |
0.3 |
GO:0046069 |
cGMP catabolic process(GO:0046069) |
0.1 |
8.5 |
GO:0018279 |
peptidyl-asparagine modification(GO:0018196) protein N-linked glycosylation via asparagine(GO:0018279) |
0.1 |
0.2 |
GO:0043461 |
proton-transporting ATP synthase complex assembly(GO:0043461) proton-transporting two-sector ATPase complex assembly(GO:0070071) proton-transporting ATP synthase complex biogenesis(GO:0070272) |
0.1 |
1.4 |
GO:0006688 |
glycosphingolipid biosynthetic process(GO:0006688) |
0.1 |
5.5 |
GO:0006469 |
negative regulation of protein kinase activity(GO:0006469) |
0.1 |
1.4 |
GO:0046466 |
sphingolipid catabolic process(GO:0030149) membrane lipid catabolic process(GO:0046466) |
0.1 |
24.3 |
GO:0097485 |
axon guidance(GO:0007411) neuron projection guidance(GO:0097485) |
0.1 |
0.4 |
GO:0019985 |
translesion synthesis(GO:0019985) |
0.1 |
0.3 |
GO:0052805 |
histidine catabolic process(GO:0006548) imidazole-containing compound catabolic process(GO:0052805) |
0.1 |
1.7 |
GO:0010771 |
negative regulation of cell morphogenesis involved in differentiation(GO:0010771) |
0.1 |
0.5 |
GO:0045446 |
endothelial cell differentiation(GO:0045446) |
0.1 |
0.2 |
GO:0090280 |
positive regulation of calcium ion import(GO:0090280) |
0.1 |
2.1 |
GO:0042147 |
retrograde transport, endosome to Golgi(GO:0042147) |
0.1 |
0.4 |
GO:0006848 |
pyruvate transport(GO:0006848) |
0.1 |
1.4 |
GO:0031032 |
actomyosin structure organization(GO:0031032) |
0.1 |
1.8 |
GO:0006749 |
glutathione metabolic process(GO:0006749) |
0.1 |
1.9 |
GO:0006693 |
prostaglandin metabolic process(GO:0006693) |
0.1 |
1.6 |
GO:0006029 |
proteoglycan metabolic process(GO:0006029) |
0.1 |
0.4 |
GO:0051881 |
regulation of mitochondrial membrane potential(GO:0051881) |
0.1 |
0.1 |
GO:0006487 |
protein N-linked glycosylation(GO:0006487) |
0.1 |
1.7 |
GO:0032011 |
ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
0.1 |
0.1 |
GO:0030497 |
fatty acid elongation(GO:0030497) |
0.1 |
2.3 |
GO:0048511 |
rhythmic process(GO:0048511) |
0.1 |
4.9 |
GO:0015718 |
monocarboxylic acid transport(GO:0015718) |
0.1 |
1.1 |
GO:0001707 |
mesoderm formation(GO:0001707) |
0.1 |
0.2 |
GO:0071624 |
positive regulation of granulocyte chemotaxis(GO:0071624) regulation of monocyte chemotaxis(GO:0090025) positive regulation of monocyte chemotaxis(GO:0090026) |
0.1 |
0.6 |
GO:0001539 |
cilium or flagellum-dependent cell motility(GO:0001539) |
0.1 |
0.7 |
GO:0050690 |
regulation of defense response to virus by virus(GO:0050690) |
0.1 |
1.5 |
GO:0043252 |
sodium-independent organic anion transport(GO:0043252) |
0.1 |
5.0 |
GO:0030308 |
negative regulation of cell growth(GO:0030308) |
0.1 |
0.6 |
GO:0035246 |
peptidyl-arginine N-methylation(GO:0035246) |
0.1 |
0.3 |
GO:0050747 |
positive regulation of lipoprotein metabolic process(GO:0050747) |
0.1 |
0.2 |
GO:0050957 |
equilibrioception(GO:0050957) |
0.1 |
0.4 |
GO:0070207 |
protein homotrimerization(GO:0070207) |
0.1 |
0.1 |
GO:0006837 |
serotonin transport(GO:0006837) |
0.1 |
0.1 |
GO:1903018 |
regulation of glycoprotein biosynthetic process(GO:0010559) regulation of glycoprotein metabolic process(GO:1903018) |
0.1 |
0.2 |
GO:0006104 |
succinyl-CoA metabolic process(GO:0006104) |
0.1 |
0.1 |
GO:0000103 |
sulfate assimilation(GO:0000103) |
0.1 |
1.2 |
GO:0009214 |
cyclic nucleotide catabolic process(GO:0009214) |
0.1 |
3.2 |
GO:0006821 |
chloride transport(GO:0006821) |
0.1 |
0.7 |
GO:0002281 |
macrophage activation involved in immune response(GO:0002281) |
0.1 |
5.7 |
GO:0007218 |
neuropeptide signaling pathway(GO:0007218) |
0.1 |
1.3 |
GO:0042094 |
interleukin-2 biosynthetic process(GO:0042094) |
0.1 |
0.3 |
GO:0055075 |
potassium ion homeostasis(GO:0055075) |
0.1 |
1.3 |
GO:0006937 |
regulation of muscle contraction(GO:0006937) |
0.1 |
0.6 |
GO:0008631 |
intrinsic apoptotic signaling pathway in response to oxidative stress(GO:0008631) cell death in response to oxidative stress(GO:0036473) |
0.1 |
0.5 |
GO:0006422 |
aspartyl-tRNA aminoacylation(GO:0006422) |
0.1 |
0.2 |
GO:0055002 |
striated muscle cell development(GO:0055002) |
0.1 |
0.1 |
GO:0033590 |
response to cobalamin(GO:0033590) |
0.1 |
0.2 |
GO:0009313 |
oligosaccharide catabolic process(GO:0009313) |
0.1 |
0.2 |
GO:0060042 |
retina morphogenesis in camera-type eye(GO:0060042) |
0.1 |
0.5 |
GO:0022027 |
interkinetic nuclear migration(GO:0022027) |
0.1 |
0.7 |
GO:0006030 |
chitin metabolic process(GO:0006030) chitin catabolic process(GO:0006032) |
0.1 |
0.2 |
GO:0046085 |
adenosine metabolic process(GO:0046085) |
0.1 |
0.5 |
GO:0048240 |
sperm capacitation(GO:0048240) |
0.1 |
0.4 |
GO:0002230 |
positive regulation of defense response to virus by host(GO:0002230) |
0.1 |
0.6 |
GO:0002062 |
chondrocyte differentiation(GO:0002062) |
0.1 |
0.7 |
GO:0007141 |
male meiosis I(GO:0007141) |
0.1 |
1.2 |
GO:0071774 |
cellular response to fibroblast growth factor stimulus(GO:0044344) response to fibroblast growth factor(GO:0071774) |
0.1 |
5.2 |
GO:0007565 |
female pregnancy(GO:0007565) |
0.1 |
2.1 |
GO:0019432 |
triglyceride biosynthetic process(GO:0019432) |
0.1 |
0.1 |
GO:0005984 |
disaccharide metabolic process(GO:0005984) |
0.1 |
0.5 |
GO:0006553 |
lysine metabolic process(GO:0006553) lysine catabolic process(GO:0006554) |
0.1 |
0.2 |
GO:0042417 |
dopamine metabolic process(GO:0042417) |
0.1 |
0.5 |
GO:0019228 |
neuronal action potential(GO:0019228) |
0.1 |
0.1 |
GO:0032914 |
positive regulation of transforming growth factor beta1 production(GO:0032914) |
0.1 |
0.8 |
GO:0006884 |
cell volume homeostasis(GO:0006884) |
0.1 |
0.1 |
GO:0035235 |
ionotropic glutamate receptor signaling pathway(GO:0035235) |
0.1 |
0.1 |
GO:0006529 |
asparagine metabolic process(GO:0006528) asparagine biosynthetic process(GO:0006529) |
0.1 |
0.6 |
GO:0015780 |
nucleotide-sugar transport(GO:0015780) |
0.1 |
0.1 |
GO:0046653 |
tetrahydrofolate metabolic process(GO:0046653) |
0.1 |
0.3 |
GO:0007632 |
visual behavior(GO:0007632) |
0.1 |
1.9 |
GO:0060271 |
cilium morphogenesis(GO:0060271) |
0.1 |
0.2 |
GO:1903510 |
mucopolysaccharide metabolic process(GO:1903510) |
0.1 |
0.5 |
GO:0017158 |
regulation of calcium ion-dependent exocytosis(GO:0017158) |
0.1 |
0.2 |
GO:0060438 |
trachea development(GO:0060438) |
0.1 |
0.2 |
GO:0072488 |
ammonium transmembrane transport(GO:0072488) |
0.1 |
0.9 |
GO:0045137 |
development of primary sexual characteristics(GO:0045137) |
0.1 |
0.2 |
GO:0007000 |
nucleolus organization(GO:0007000) |
0.1 |
0.4 |
GO:0006610 |
ribosomal protein import into nucleus(GO:0006610) |
0.1 |
1.5 |
GO:0007338 |
single fertilization(GO:0007338) |
0.1 |
0.2 |
GO:0007506 |
gonadal mesoderm development(GO:0007506) |
0.1 |
0.3 |
GO:0007271 |
synaptic transmission, cholinergic(GO:0007271) |
0.1 |
0.1 |
GO:0034551 |
respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) mitochondrial respiratory chain complex III biogenesis(GO:0097033) |
0.1 |
2.1 |
GO:0042157 |
lipoprotein metabolic process(GO:0042157) |
0.1 |
0.2 |
GO:0007256 |
activation of JNKK activity(GO:0007256) |
0.1 |
0.2 |
GO:0046580 |
negative regulation of Ras protein signal transduction(GO:0046580) |
0.1 |
0.3 |
GO:0003322 |
pancreatic A cell development(GO:0003322) |
0.1 |
0.4 |
GO:0007168 |
receptor guanylyl cyclase signaling pathway(GO:0007168) |
0.1 |
1.0 |
GO:0009812 |
flavonoid metabolic process(GO:0009812) |
0.1 |
0.1 |
GO:0070528 |
protein kinase C signaling(GO:0070528) |
0.1 |
0.9 |
GO:0016197 |
endosomal transport(GO:0016197) |
0.1 |
2.0 |
GO:0030048 |
actin filament-based movement(GO:0030048) |
0.1 |
0.2 |
GO:0030488 |
tRNA methylation(GO:0030488) |
0.1 |
0.4 |
GO:0006590 |
thyroid hormone generation(GO:0006590) |
0.1 |
0.3 |
GO:0007023 |
post-chaperonin tubulin folding pathway(GO:0007023) |
0.0 |
5.2 |
GO:0006814 |
sodium ion transport(GO:0006814) |
0.0 |
0.2 |
GO:0033189 |
response to vitamin A(GO:0033189) |
0.0 |
0.0 |
GO:0016081 |
synaptic vesicle docking(GO:0016081) |
0.0 |
0.0 |
GO:0000019 |
regulation of mitotic recombination(GO:0000019) |
0.0 |
0.7 |
GO:0001822 |
kidney development(GO:0001822) renal system development(GO:0072001) |
0.0 |
0.1 |
GO:0016056 |
rhodopsin mediated signaling pathway(GO:0016056) |
0.0 |
0.5 |
GO:0006891 |
intra-Golgi vesicle-mediated transport(GO:0006891) |
0.0 |
0.4 |
GO:0000028 |
ribosomal small subunit assembly(GO:0000028) |
0.0 |
0.5 |
GO:0051865 |
protein autoubiquitination(GO:0051865) |
0.0 |
0.1 |
GO:0007538 |
primary sex determination(GO:0007538) |
0.0 |
0.1 |
GO:0009750 |
response to fructose(GO:0009750) |
0.0 |
0.4 |
GO:0001933 |
negative regulation of protein phosphorylation(GO:0001933) |
0.0 |
0.1 |
GO:0032506 |
barrier septum assembly(GO:0000917) cytokinetic process(GO:0032506) cell septum assembly(GO:0090529) mitotic cytokinetic process(GO:1902410) |
0.0 |
0.1 |
GO:0006420 |
arginyl-tRNA aminoacylation(GO:0006420) |
0.0 |
0.2 |
GO:0071941 |
nitrogen cycle metabolic process(GO:0071941) |
0.0 |
0.2 |
GO:0007212 |
dopamine receptor signaling pathway(GO:0007212) |
0.0 |
0.0 |
GO:0032328 |
alanine transport(GO:0032328) |
0.0 |
0.2 |
GO:0008038 |
neuron recognition(GO:0008038) |
0.0 |
0.0 |
GO:2001021 |
negative regulation of response to DNA damage stimulus(GO:2001021) |
0.0 |
0.1 |
GO:0048265 |
response to pain(GO:0048265) |
0.0 |
0.2 |
GO:0015824 |
proline transport(GO:0015824) |
0.0 |
0.2 |
GO:0071599 |
otic vesicle formation(GO:0030916) otic vesicle development(GO:0071599) otic vesicle morphogenesis(GO:0071600) |
0.0 |
0.0 |
GO:0016188 |
synaptic vesicle maturation(GO:0016188) |
0.0 |
0.1 |
GO:0046520 |
diol biosynthetic process(GO:0034312) sphingosine biosynthetic process(GO:0046512) sphingoid biosynthetic process(GO:0046520) |
0.0 |
0.1 |
GO:0035383 |
acyl-CoA metabolic process(GO:0006637) thioester metabolic process(GO:0035383) |
0.0 |
0.7 |
GO:0007498 |
mesoderm development(GO:0007498) |
0.0 |
0.2 |
GO:0071157 |
negative regulation of cell cycle arrest(GO:0071157) |
0.0 |
0.1 |
GO:0000244 |
spliceosomal tri-snRNP complex assembly(GO:0000244) |
0.0 |
0.1 |
GO:0072595 |
maintenance of protein localization in organelle(GO:0072595) |
0.0 |
0.1 |
GO:0070192 |
synapsis(GO:0007129) chromosome organization involved in meiotic cell cycle(GO:0070192) |
0.0 |
0.2 |
GO:0045669 |
positive regulation of osteoblast differentiation(GO:0045669) |
0.0 |
0.1 |
GO:0045926 |
negative regulation of growth(GO:0045926) |
0.0 |
0.1 |
GO:0042326 |
negative regulation of phosphorylation(GO:0042326) |
0.0 |
0.1 |
GO:1902600 |
hydrogen ion transmembrane transport(GO:1902600) |
0.0 |
0.4 |
GO:0006750 |
glutathione biosynthetic process(GO:0006750) |
0.0 |
0.3 |
GO:0032526 |
response to retinoic acid(GO:0032526) |
0.0 |
0.1 |
GO:0010457 |
centriole-centriole cohesion(GO:0010457) |
0.0 |
0.1 |
GO:0034375 |
high-density lipoprotein particle remodeling(GO:0034375) |
0.0 |
0.5 |
GO:0032784 |
regulation of DNA-templated transcription, elongation(GO:0032784) |
0.0 |
0.2 |
GO:0006702 |
androgen biosynthetic process(GO:0006702) |
0.0 |
0.0 |
GO:0051823 |
regulation of synapse structural plasticity(GO:0051823) |
0.0 |
0.1 |
GO:2000398 |
regulation of T cell differentiation in thymus(GO:0033081) regulation of thymocyte aggregation(GO:2000398) |
0.0 |
0.2 |
GO:0050892 |
intestinal absorption(GO:0050892) |
0.0 |
0.0 |
GO:0006878 |
cellular copper ion homeostasis(GO:0006878) |
0.0 |
0.1 |
GO:0070172 |
positive regulation of tooth mineralization(GO:0070172) |
0.0 |
0.2 |
GO:0009311 |
oligosaccharide metabolic process(GO:0009311) |
0.0 |
0.1 |
GO:0060359 |
response to ammonium ion(GO:0060359) |
0.0 |
0.3 |
GO:0009404 |
toxin metabolic process(GO:0009404) |
0.0 |
0.1 |
GO:1901343 |
negative regulation of vasculature development(GO:1901343) |
0.0 |
0.1 |
GO:0006547 |
histidine metabolic process(GO:0006547) imidazole-containing compound metabolic process(GO:0052803) |
0.0 |
0.2 |
GO:0046835 |
carbohydrate phosphorylation(GO:0046835) |
0.0 |
0.5 |
GO:0046470 |
phosphatidylcholine metabolic process(GO:0046470) |
0.0 |
0.0 |
GO:0006655 |
phosphatidylglycerol biosynthetic process(GO:0006655) cardiolipin metabolic process(GO:0032048) cardiolipin biosynthetic process(GO:0032049) phosphatidylglycerol metabolic process(GO:0046471) |
0.0 |
0.1 |
GO:0009136 |
ADP biosynthetic process(GO:0006172) purine nucleoside diphosphate biosynthetic process(GO:0009136) purine ribonucleoside diphosphate biosynthetic process(GO:0009180) ribonucleoside diphosphate biosynthetic process(GO:0009188) |
0.0 |
0.0 |
GO:0030157 |
pancreatic juice secretion(GO:0030157) |
0.0 |
0.2 |
GO:0008535 |
respiratory chain complex IV assembly(GO:0008535) |
0.0 |
0.1 |
GO:0009799 |
specification of symmetry(GO:0009799) |
0.0 |
0.1 |
GO:0007285 |
primary spermatocyte growth(GO:0007285) |
0.0 |
1.0 |
GO:0006633 |
fatty acid biosynthetic process(GO:0006633) |
0.0 |
0.0 |
GO:0052510 |
modulation by symbiont of host defense response(GO:0052031) modulation by organism of defense response of other organism involved in symbiotic interaction(GO:0052255) positive regulation by symbiont of host defense response(GO:0052509) positive regulation by organism of defense response of other organism involved in symbiotic interaction(GO:0052510) modulation by organism of immune response of other organism involved in symbiotic interaction(GO:0052552) modulation by symbiont of host immune response(GO:0052553) |
0.0 |
0.1 |
GO:0007274 |
neuromuscular synaptic transmission(GO:0007274) |
0.0 |
0.0 |
GO:0021854 |
hypothalamus development(GO:0021854) |
0.0 |
2.7 |
GO:0007601 |
visual perception(GO:0007601) |
0.0 |
0.0 |
GO:0048484 |
enteric nervous system development(GO:0048484) |
0.0 |
0.0 |
GO:0015705 |
iodide transport(GO:0015705) |
0.0 |
0.2 |
GO:0006706 |
steroid catabolic process(GO:0006706) |
0.0 |
0.2 |
GO:0016226 |
iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
0.0 |
0.1 |
GO:0006906 |
vesicle fusion(GO:0006906) |
0.0 |
0.1 |
GO:0007258 |
JUN phosphorylation(GO:0007258) |
0.0 |
0.0 |
GO:0032196 |
transposition, DNA-mediated(GO:0006313) transposition(GO:0032196) |
0.0 |
0.1 |
GO:0098764 |
meiosis I cell cycle phase(GO:0098764) |
0.0 |
0.0 |
GO:0006669 |
sphinganine-1-phosphate biosynthetic process(GO:0006669) |
0.0 |
3.5 |
GO:0007186 |
G-protein coupled receptor signaling pathway(GO:0007186) |
0.0 |
0.0 |
GO:0006428 |
isoleucyl-tRNA aminoacylation(GO:0006428) |
0.0 |
1.2 |
GO:0007156 |
homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
0.0 |
0.1 |
GO:0090083 |
regulation of inclusion body assembly(GO:0090083) |
0.0 |
0.1 |
GO:0022600 |
digestive system process(GO:0022600) |
0.0 |
0.0 |
GO:0031122 |
cytoplasmic microtubule organization(GO:0031122) |
0.0 |
0.1 |
GO:0030224 |
monocyte differentiation(GO:0030224) |
0.0 |
1.7 |
GO:0006415 |
translational termination(GO:0006415) |
0.0 |
0.0 |
GO:0015811 |
sulfur amino acid transport(GO:0000101) L-cystine transport(GO:0015811) |